Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer.

Dr. Syed Hussain with Trinity Health of New England discusses the latest and trending health topics happening around the country.

Michael Strahan’s daughter Isabella joins us live to talk about the ABC News special airing tonight about her journey with ...

Check your stash as soon as you can. Daily, low-dose aspirin is no longer recommended for the prevention of stroke and heart ...

Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

Visakhapatnam: Drug repurposing is emerging as a promising strategy for tackling drug-resistant and metastatic cancers.

Persistent itching or tingling in one spot – Some skin cancers affect the nerves, leading to unusual sensations before ...

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...